Health Care Deal News: Spotlight on Pharmaceuticals- April 2012
GlaxoSmithKline continues the sell-off of its generic drugs. In March, it announced selling a portfolio of European over-the-counter drugs to Belgium’s Omega Pharma for approximately $612.0 million. The portfolio includes Solpadeine (pain), Zantac (stomach acid) and...Health Care Deal News: Spotlight on Medical Devices – April 2012
In March’s largest deal in any sector of health care, Boston Scientific (NYSE: BSX) is offering to acquire Cameron Health for as much as $1.35 billion. Based in San Clemente, California, Cameron’s S-ICD wireless system is the only commercially available subcutaneous...The Dealmakers Forum E-Newsletter- April 25, 2012
Bringing You Senior Care M&A Deals and News April 25, 2012 Issue: Seniors Housing Weekly Update: 60 Seconds with Steve Monroe Recent Senior Care M&A Deals Expert Opinion: A Conversation with Jim Sherman Conference Calendar Seniors Housing Weekly...Health Care Deal News: Spotlight on Medical Devices – March 2012
Although the Medical Device sector saw robust deal volume in February, the (revealed) prices were rather modest. In the largest deal with a disclosed price, Linden, LLC, a Chicago-based private equity shop, has offered to acquire SeraCare Life Sciences (NASDAQ:...Health Care Deal News: Spotlight on Pharmaceuticals- March 2012
With big pharma concentrating on Biotechnology this month, February saw no grand gestures in the Pharmaceutical M&A market. Impax Laboratories (NASDAQ: IPXL) acquired the U.S. rights to AstraZeneca’s (NYSE: AZN) migraine headache drug, Zomig. It is sold as a...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
